Rosuvastatin

BNF:
2.12
Status:
Do Not Prescribe (DNP), Grey
Decision Date:
May 2013
 

Comments

GREY:

  • Familial hypercholesterolemia: GREY 2nd line treatment option. See FH guidance for further details.  (Decision date - November 2020) 
  • Non-familial hypercholesterolemia: GREY 2nd line alternative treatment option after atorvastatin. Can also be used when there is complete intolerance to atorvastatin or partial intolerance to other statins. See non-FH guidance for further details. (Decision date - December 2020) 

 Cost-effective to prescribe generically.

DO NOT PRESCRIBE (DNP): Not to be prescribed by brand - Crestor. (Decision date - August 2019)

 

search again

Derby and Derbyshire CCG

Derby and Derbyshire CCG